Physician profile
Daniel S Foreman
NPI 1174565303
$7,233.54
in general payments reported to CMS, 2019-2025
28 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $296 · 2021: $454 · 2022: $676 · 2023: $1,406 · 2024: $1,645 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,699.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,986.08 | 2019-2025 | Idosetr, Idose, Istent Inject Trabecular Micro-Bypass System |
| Alcon Vision LLC | $1,071.39 | 2019-2025 | Clareon, Lensx, Rocklatan |
| Abbvie INC. | $893.20 | 2022-2025 | |
| New World Medical,INC. | $570.44 | 2019-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Bausch & Lomb Americas INC. | $479.64 | 2023-2025 | Envista Envy Iol, Vyzulta, Miebo |
| Carl Zeiss Meditec, INC. | $347.01 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $276.76 | 2023-2024 | Artevo 800, Iolmaster 700, Callisto Eye |
| Allergan, INC. | $204.82 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $167.65 | 2020-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $137.42 | 2019-2021 | |
| Rxsight INC | $127.17 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Aerie Pharmaceuticals, INC. | $124.41 | 2019 | |
| Sun Pharmaceutical Industries INC. | $119.42 | 2019-2025 | |
| Thea Pharma INC. | $92.83 | 2023-2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $81.18 | 2024-2025 | Xdemvy |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $70.23 | 2023-2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Biotissue Holdings INC. | $68.12 | 2019-2025 | |
| Apellis Pharmaceuticals, INC. | $63.12 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $59.34 | 2021-2022 | |
| Dompe US, INC. | $55.83 | 2021-2025 | Oxervate |
| Amgen INC. | $45.93 | 2024-2025 | Tepezza |
| Sight Sciences, INC. | $45.93 | 2019-2024 | Omni Surgical System |
| Oyster Point Pharma, INC. | $36.81 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $35.93 | 2019 | |
| Optos, INC. | $20.23 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $19.12 | 2019 | |
| Shire North American Group INC | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.